A carregar...
Early Hydroxychloroquine Administration for Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Eradication
There are no proven therapeutics for Coronavirus disease 2019 (COVID-19) pneumonia outbreak. We observed and analyzed the clinical efficacy of the most used hydroxychloroquine (HCQ) for 30 days. In this study, administration of HCQ <5 days from diagnosis (odds ratio: 0.111, 95% confidence interva...
Na minha lista:
| Publicado no: | Infect Chemother |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
The Korean Society of Infectious Diseases and Korean Society for Chemotherapy
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7533217/ https://ncbi.nlm.nih.gov/pubmed/32757497 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3947/ic.2020.52.3.396 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|